Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Shenzhen Kexing Pharmaceutical Co., Ltd.
Company

Shenzhen Kexing Pharmaceutical Co., Ltd.

Tracked across 1 events · 7 articles · First seen Jun 04, 2026 · Last active Jun 04, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 70
Business
Kexing Biopharm GB10 Phase I Trial
Impact: Shenzhen Kexing Pharmaceutical Co., Ltd. independently developed GB10 Injection, an innovative ophthalmic drug. The enrollment of the first subject in its Phase I clinical trial is a key achievement for the company.
Jun 04, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Shenzhen Kexing Pharmaceutical Co., Ltd. live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.